Fig. 6
From: Identification of comutation in signaling pathways to predict the clinical outcomes of immunotherapy
Pooled analysis of PFS, OS, and ORR comparing the SpHe-comut+ and SpHe-comut− patients across different cohorts. A Kaplan–Meier survival curves of PFS comparing the SpHe-comut+ and SpHe-comut− groups in the Hellmann cohort. B, C Kaplan–Meier survival curves of OS comparing the SpHe-comut+ and SpHe-comut− groups in the Allen and Snyder cohort (B) and the MSKCC cohort (C). D–F Pooled estimates of ORR (D), PFS (E), and OS (F) comparing SpHe-comut+ and SpHe-comut− patients across different cohorts